Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

A sensitive LC-MS assay using derivatization with boron trifluoride to quantify curcuminoids in biological samples.

Yoon AJ, Wu H, Pan RD, Teter B, Cipolla J, Chang E, Avila LZ, Basak SK, Srivatsan ES, Wang MB, Cole GM, Frautschy SA, Hampton PD, Faull KF.

Anal Biochem. 2020 Feb 17;596:113636. doi: 10.1016/j.ab.2020.113636. [Epub ahead of print]

PMID:
32081619
2.

A randomized, phase 1, placebo-controlled trial of APG-157 in oral cancer demonstrates systemic absorption and an inhibitory effect on cytokines and tumor-associated microbes.

Basak SK, Bera A, Yoon AJ, Morselli M, Jeong C, Tosevska A, Dong TS, Eklund M, Russ E, Nasser H, Lagishetty V, Guo R, Sajed D, Mudgal S, Mehta P, Avila L, Srivastava M, Faull K, Jacobs J, Pellegrini M, Shin DS, Srivatsan ES, Wang MB.

Cancer. 2020 Apr 15;126(8):1668-1682. doi: 10.1002/cncr.32644. Epub 2020 Feb 5.

PMID:
32022261
3.

Synergistic Activity with NOTCH Inhibition and Androgen Ablation in ERG-Positive Prostate Cancer Cells.

Mohamed AA, Tan SH, Xavier CP, Katta S, Huang W, Ravindranath L, Jamal M, Li H, Srivastava M, Srivatsan ES, Sreenath TL, McLeod DG, Srinivasan A, Petrovics G, Dobi A, Srivastava S.

Mol Cancer Res. 2017 Oct;15(10):1308-1317. doi: 10.1158/1541-7786.MCR-17-0058. Epub 2017 Jun 12.

4.

Human papillomavirus in oropharyngeal cancer: The changing face of a disease.

Mallen-St Clair J, Alani M, Wang MB, Srivatsan ES.

Biochim Biophys Acta. 2016 Dec;1866(2):141-150. doi: 10.1016/j.bbcan.2016.07.005. Epub 2016 Jul 31. Review.

PMID:
27487173
5.

Cystatin E/M Suppresses Tumor Cell Growth through Cytoplasmic Retention of NF-κB.

Soh H, Venkatesan N, Veena MS, Ravichandran S, Zinabadi A, Basak SK, Parvatiyar K, Srivastava M, Liang LJ, Gjertson DW, Torres JZ, Moatamed NA, Srivatsan ES.

Mol Cell Biol. 2016 May 31;36(12):1776-92. doi: 10.1128/MCB.00878-15. Print 2016 Jun 15.

6.

A review of gigaxonin mutations in giant axonal neuropathy (GAN) and cancer.

Kang JJ, Liu IY, Wang MB, Srivatsan ES.

Hum Genet. 2016 Jul;135(7):675-84. doi: 10.1007/s00439-016-1659-5. Epub 2016 Mar 29. Review.

PMID:
27023907
7.

Liposome encapsulated curcumin-difluorinated (CDF) inhibits the growth of cisplatin resistant head and neck cancer stem cells.

Basak SK, Zinabadi A, Wu AW, Venkatesan N, Duarte VM, Kang JJ, Dalgard CL, Srivastava M, Sarkar FH, Wang MB, Srivatsan ES.

Oncotarget. 2015 Jul 30;6(21):18504-17.

8.

p16 Protein and gigaxonin are associated with the ubiquitination of NFκB in cisplatin-induced senescence of cancer cells.

Veena MS, Wilken R, Zheng JY, Gholkar A, Venkatesan N, Vira D, Ahmed S, Basak SK, Dalgard CL, Ravichandran S, Batra RK, Kasahara N, Elashoff D, Fishbein MC, Whitelegge JP, Torres JZ, Wang MB, Srivatsan ES.

J Biol Chem. 2014 Dec 12;289(50):34921-37. doi: 10.1074/jbc.M114.568543. Epub 2014 Oct 20.

9.

One in four individuals of African-American ancestry harbors a 5.5kb deletion at chromosome 11q13.1.

Zainabadi K, Jain AV, Donovan FX, Elashoff D, Rao NP, Murty VV, Chandrasekharappa SC, Srivatsan ES.

Genomics. 2014 Apr;103(4):276-87. doi: 10.1016/j.ygeno.2014.01.001. Epub 2014 Jan 10.

10.

Correction: The CD44high Tumorigenic Subsets in Lung Cancer Biospecimens Are Enriched for Low miR-34a Expression.

Basak SK, Veena MS, Oh S, Lai C, Vangala S, Elashoff D, Fishbein MC, Sharma S, Rao NP, Rao D, Phan R, Srivatsan ES, Batra RK.

PLoS One. 2013 Sep 30;8(9). doi: 10.1371/annotation/9ae8db84-5d44-4a9c-bb80-47c9d68820ea. eCollection 2013.

11.

The CD44(high) tumorigenic subsets in lung cancer biospecimens are enriched for low miR-34a expression.

Basak SK, Veena MS, Oh S, Lai C, Vangala S, Elashoff D, Fishbein MC, Sharma S, Rao NP, Rao D, Phan R, Srivatsan ES, Batra RK.

PLoS One. 2013 Sep 3;8(9):e73195. doi: 10.1371/journal.pone.0073195. eCollection 2013. Erratum in: PLoS One. 2013;8(9). doi:10.1371/annotation/9ae8db84-5d44-4a9c-bb80-47c9d68820ea.

12.

Hyperactivated JNK is a therapeutic target in pVHL-deficient renal cell carcinoma.

An J, Liu H, Magyar CE, Guo Y, Veena MS, Srivatsan ES, Huang J, Rettig MB.

Cancer Res. 2013 Feb 15;73(4):1374-85. doi: 10.1158/0008-5472.CAN-12-2362. Epub 2013 Feb 7.

13.

Cancer stem cells, microRNAs, and therapeutic strategies including natural products.

Vira D, Basak SK, Veena MS, Wang MB, Batra RK, Srivatsan ES.

Cancer Metastasis Rev. 2012 Dec;31(3-4):733-51. doi: 10.1007/s10555-012-9382-8. Review.

PMID:
22752409
14.

Cellular senescence and tumor suppressor gene p16.

Rayess H, Wang MB, Srivatsan ES.

Int J Cancer. 2012 Apr 15;130(8):1715-25. doi: 10.1002/ijc.27316. Epub 2011 Dec 5. Review.

15.

Curcumin treatment suppresses IKKβ kinase activity of salivary cells of patients with head and neck cancer: a pilot study.

Kim SG, Veena MS, Basak SK, Han E, Tajima T, Gjertson DW, Starr J, Eidelman O, Pollard HB, Srivastava M, Srivatsan ES, Wang MB.

Clin Cancer Res. 2011 Sep 15;17(18):5953-61. doi: 10.1158/1078-0432.CCR-11-1272. Epub 2011 Aug 5.

16.

Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma.

Wilken R, Veena MS, Wang MB, Srivatsan ES.

Mol Cancer. 2011 Feb 7;10:12. doi: 10.1186/1476-4598-10-12. Review.

17.

Curcumin enhances the effect of cisplatin in suppression of head and neck squamous cell carcinoma via inhibition of IKKβ protein of the NFκB pathway.

Duarte VM, Han E, Veena MS, Salvado A, Suh JD, Liang LJ, Faull KF, Srivatsan ES, Wang MB.

Mol Cancer Ther. 2010 Oct;9(10):2665-75. doi: 10.1158/1535-7163.MCT-10-0064.

18.

Suppression of interleukin 6 and 8 production in head and neck cancer cells with curcumin via inhibition of Ikappa beta kinase.

Cohen AN, Veena MS, Srivatsan ES, Wang MB.

Arch Otolaryngol Head Neck Surg. 2009 Feb;135(2):190-7. doi: 10.1001/archotol.135.2.190.

PMID:
19221248
19.

Inactivation of the CYLD deubiquitinase by HPV E6 mediates hypoxia-induced NF-kappaB activation.

An J, Mo D, Liu H, Veena MS, Srivatsan ES, Massoumi R, Rettig MB.

Cancer Cell. 2008 Nov 4;14(5):394-407. doi: 10.1016/j.ccr.2008.10.007.

20.

Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway.

Wang D, Veena MS, Stevenson K, Tang C, Ho B, Suh JD, Duarte VM, Faull KF, Mehta K, Srivatsan ES, Wang MB.

Clin Cancer Res. 2008 Oct 1;14(19):6228-36. doi: 10.1158/1078-0432.CCR-07-5177.

21.

Inactivation of the cystatin E/M tumor suppressor gene in cervical cancer.

Veena MS, Lee G, Keppler D, Mendonca MS, Redpath JL, Stanbridge EJ, Wilczynski SP, Srivatsan ES.

Genes Chromosomes Cancer. 2008 Sep;47(9):740-54. doi: 10.1002/gcc.20576.

22.

Cisplatin-induced growth arrest of head and neck cancer cells correlates with increased expression of p16 and p53.

Yip HT, Chopra R, Chakrabarti R, Veena MS, Ramamurthy B, Srivatsan ES, Wang MB.

Arch Otolaryngol Head Neck Surg. 2006 Mar;132(3):317-26.

PMID:
16549753
23.

Curcumin suppresses growth of head and neck squamous cell carcinoma.

LoTempio MM, Veena MS, Steele HL, Ramamurthy B, Ramalingam TS, Cohen AN, Chakrabarti R, Srivatsan ES, Wang MB.

Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6994-7002.

24.

A 700-kb physical and transcription map of the cervical cancer tumor suppressor gene locus on chromosome 11q13.

Zainabadi K, Benyamini P, Chakrabarti R, Veena MS, Chandrasekharappa SC, Gatti RA, Srivatsan ES.

Genomics. 2005 Jun;85(6):704-14. Epub 2005 Apr 9.

PMID:
15885497
25.

Homozygous deletions within the 11q13 cervical cancer tumor-suppressor locus in radiation-induced, neoplastically transformed human hybrid cells.

Mendonca MS, Farrington DL, Mayhugh BM, Qin Y, Temples T, Comerford K, Chakrabarti R, Zainabadi K, Redpath JL, Stanbridge EJ, Srivatsan ES.

Genes Chromosomes Cancer. 2004 Apr;39(4):277-87.

PMID:
14978789
26.

Fluorescence in situ hybridization for detecting TP16 MTS1/CDK41 gene deletions in squamous cell carcinoma of the head and neck.

Namazie A, Alavi S, Aghamohammadi N, Aghamohammadi M, Calcaterra TC, Wang MB, Srivatsan ES.

Cancer Genet Cytogenet. 2003 Feb;141(1):49-55.

PMID:
12581898
27.

Localization of deletion to a 300 Kb interval of chromosome 11q13 in cervical cancer.

Srivatsan ES, Chakrabarti R, Zainabadi K, Pack SD, Benyamini P, Mendonca MS, Yang PK, Kang K, Motamedi D, Sawicki MP, Zhuang Z, Jesudasan RA, Bengtsson U, Sun C, Roe BA, Stanbridge EJ, Wilczynski SP, Redpath JL.

Oncogene. 2002 Aug 15;21(36):5631-42.

28.

Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.

Namazie A, Alavi S, Olopade OI, Pauletti G, Aghamohammadi N, Aghamohammadi M, Gornbein JA, Calcaterra TC, Slamon DJ, Wang MB, Srivatsan ES.

Laryngoscope. 2002 Mar;112(3):472-81.

PMID:
12148857
29.

Mapping of nasopharyngeal carcinoma tumor-suppressive activity to a 1.8-megabase region of chromosome band 11q13.

Cheng Y, Chakrabarti R, Garcia-Barcelo M, Ha TJ, Srivatsan ES, Stanbridge EJ, Lung ML.

Genes Chromosomes Cancer. 2002 May;34(1):97-103.

PMID:
11921287
30.

Alternative mRNA splicing in colon cancer causes loss of expression of neural cell adhesion molecule.

Huerta S, Srivatsan ES, Venkatesan N, Peters J, Moatamed F, Renner S, Livingston EH.

Surgery. 2001 Nov;130(5):834-43.

PMID:
11685193
31.

Human colon cancer cells deficient in DCC produce abnormal transcripts in progression of carcinogenesis.

Huerta S, Srivatsan ES, Venkatasan N, Livingston EH.

Dig Dis Sci. 2001 Sep;46(9):1884-91.

PMID:
11575440
32.

Antisense cyclin D1 enhances sensitivity of head and neck cancer cells to cisplatin.

Wang MB, Yip HT, Srivatsan ES.

Laryngoscope. 2001 Jun;111(6):982-8.

PMID:
11404608
33.

Third place--Resident Research Competition, AAO-2000. Antisense cyclin D1 inhibits growth of head and neck cancer xenografts in nude mice.

Wang SJ, Mintz LE, Natarajan V, Lee NJ, Srivatsan ES, Wang MB.

Otolaryngol Head Neck Surg. 2001 Jun;124(6):656-62.

PMID:
11391257
34.

Interstitial deletion of 11q13 sequences in HeLa cells.

Srivatsan ES, Bengtsson U, Manickam P, Benyamini P, Chandrasekharappa SC, Sun C, Stanbridge EJ, Redpath JL.

Genes Chromosomes Cancer. 2000 Oct;29(2):157-65.

PMID:
10959095
35.
36.

Clinical application of fluorescence in situ hybridization for chromosome 11q13 analysis in head and neck cancer.

Alavi S, Namazie A, Calcaterra TC, Wang MB, Srivatsan ES.

Laryngoscope. 1999 Jun;109(6):874-9.

PMID:
10369274
37.

Detection of chromosome 11q13 amplification in head and neck cancer using fluorescence in situ hybridization.

Wang MB, Alavi S, Engstrom M, Lee J, Namazie A, Moatamed F, Srivatsan ES.

Anticancer Res. 1999 Mar-Apr;19(2A):925-31.

PMID:
10368635
38.

Comparison of growth factor expression in fetal and adult fibroblasts: a preliminary report.

Broker BJ, Chakrabarti R, Blynman T, Roesler J, Wang MB, Srivatsan ES.

Arch Otolaryngol Head Neck Surg. 1999 Jun;125(6):676-80.

PMID:
10367926
39.

Inhibition of cell proliferation in head and neck squamous cell carcinoma cell lines with antisense cyclin D1.

Wang MB, Billings KR, Venkatesan N, Hall FL, Srivatsan ES.

Otolaryngol Head Neck Surg. 1998 Dec;119(6):593-9.

PMID:
9852531
40.

Loss of heterozygosity in squamous cell carcinomas of the head and neck defines a tumor suppressor gene region on 11q13.

Venugopalan M, Wood TF, Wilczynski SP, Sen S, Peters J, Ma GC, Evans GA, Srivatsan ES.

Cancer Genet Cytogenet. 1998 Jul 15;104(2):124-32.

PMID:
9666806
41.

Deletion mapping of endocrine tumors localizes a second tumor suppressor gene on chromosome band 11q13.

Chakrabarti R, Srivatsan ES, Wood TF, Eubanks PJ, Ebrahimi SA, Gatti RA, Passaro E Jr, Sawicki MP.

Genes Chromosomes Cancer. 1998 Jun;22(2):130-7.

PMID:
9598800
42.

Deletion analysis of the p16/CDKN2 gene in head and neck squamous cell carcinoma using quantitative polymerase chain reaction method.

Rawnsley JD, Srivatsan ES, Chakrabarti R, Billings KR, Wang MB.

Arch Otolaryngol Head Neck Surg. 1997 Aug;123(8):863-7.

PMID:
9260553
43.

A transcript map encompassing the multiple endocrine neoplasia type-1 (MEN1) locus on chromosome 11q13.

Sawicki M, Arnold E, Ebrahimi S, Duell T, Jin S, Wood T, Chakrabarti R, Peters J, Wan Y, Samara G, Weier HU, Udar N, Passaro E Jr, Srivatsan ES.

Genomics. 1997 Jun 15;42(3):405-12.

PMID:
9205112
44.

A 1.5-megabase physical map encompassing the multiple endocrine neoplasia type-1 (MEN1) locus on chromosome 11q13.

Wood TF, Srivatsan ES, Chakrabarti R, Ma GC, Kuan N, Samara GJ, Higgins MJ, Shows TB, Johnson CL, Wan YJ, Passaro EP Jr, Sawicki MP.

Genomics. 1996 Dec 1;38(2):166-73. Erratum in: Genomics 1997 May 15;42(1):183.

PMID:
8954798
45.

Loss of a putative tumor suppressor locus after gamma-ray-induced neoplastic transformation of HeLa x skin fibroblast human cell hybrids.

Mendonca MS, Fasching CL, Srivatsan ES, Stanbridge EJ, Redpath JL.

Radiat Res. 1995 Jul;143(1):34-44.

PMID:
7597142
46.

Deletion and translocation of chromosome 11q13 sequences in cervical carcinoma cell lines.

Jesudasan RA, Rahman RA, Chandrashekharappa S, Evans GA, Srivatsan ES.

Am J Hum Genet. 1995 Mar;56(3):705-15.

47.

Rearrangement of chromosome band 11q13 in HeLa cells.

Jesudasan RA, Slovak ML, Sen S, Srivatsan ES.

Anticancer Res. 1994 Sep-Oct;14(5A):1727-33.

PMID:
7847806
48.

Deletion of chromosome 11 and of 14q sequences in neuroblastoma.

Srivatsan ES, Ying KL, Seeger RC.

Genes Chromosomes Cancer. 1993 May;7(1):32-7.

PMID:
7688553
49.

Loss of heterozygosity for alleles on chromosome II in cervical carcinoma.

Srivatsan ES, Misra BC, Venugopalan M, Wilczynski SP.

Am J Hum Genet. 1991 Oct;49(4):868-77.

50.

Loss of heterozygosity for alleles on chromosomes 11q and 14q in neuroblastoma.

Srivatsan ES, Murali V, Seeger RC.

Prog Clin Biol Res. 1991;366:91-8.

PMID:
2068183

Supplemental Content

Loading ...
Support Center